ANDA 40460, held by Elite Labs Inc. Phentermine Hydrochloride.
As of Nov 16, 2026, ANDA 40460 (Phentermine Hydrochloride), held by Elite Labs Inc, was first approved by FDA on Jan 14, 2003, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 14, 2003 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phentermine Hydrochloride15MG · capsule;oral | Phentermine Hydrochloride | Discontinued |
| May 31, 2017 | Supplement 6Labeling · Standard review | Approved | None posted |
| Jan 6, 2004 | Supplement 1Labeling | Approved | None posted |
| Jan 14, 2003 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters